PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2005. Start Trial.
Date Value
November 18, 2026 5.083
November 17, 2026 5.024
November 16, 2026 5.293
November 13, 2026 5.03
November 12, 2026 5.208
November 11, 2026 5.027
November 10, 2026 5.027
November 09, 2026 5.188
November 06, 2026 5.119
November 05, 2026 5.151
November 04, 2026 5.151
November 03, 2026 5.135
November 02, 2026 5.147
October 30, 2026 5.251
October 29, 2026 5.135
October 28, 2026 4.977
October 27, 2026 4.977
October 26, 2026 4.977
October 23, 2026 5.164
October 22, 2026 5.030
October 21, 2026 5.030
October 20, 2026 5.024
October 19, 2026 4.805
October 16, 2026 4.805
October 15, 2026 4.805
Date Value
October 14, 2026 4.821
October 13, 2026 4.635
October 12, 2026 4.867
October 09, 2026 4.642
October 08, 2026 4.431
October 07, 2026 4.567
October 06, 2026 4.485
October 05, 2026 4.401
October 02, 2026 4.401
October 01, 2026 4.454
September 30, 2026 4.493
September 29, 2026 4.467
September 28, 2026 4.800
September 25, 2026 4.556
September 24, 2026 4.800
September 23, 2026 4.823
September 22, 2026 4.756
September 21, 2026 4.663
September 18, 2026 4.663
September 17, 2026 4.695
September 16, 2026 4.488
September 15, 2026 4.548
September 14, 2026 4.548
September 11, 2026 4.538
September 10, 2026 4.538

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Novartis AG 5.239
Eli Lilly & Co. 14.16
Bristol Myers Squibb Co. 2.386
Merck & Co., Inc. 4.894
Pfizer Inc. 2.478

PS Ratio Related Metrics